These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3370846)

  • 1. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of increase in concentrations of cerebrospinal fluid sodium in rats with various stages of DOCA-salt hypertension.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Life Sci; 1988; 42(12):1223-9. PubMed ID: 3347147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):45S-48S. PubMed ID: 3415808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the sympathetic nervous system and vasopressin on the blood pressure lowering effect of nifedipine in deoxycorticosterone acetate-salt hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Sci (Lond); 1987 Sep; 73(3):253-8. PubMed ID: 3652632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
    Berecek KH; Mah SC; Baum P; Hofbauer KG
    J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Tomita Y; Tsuchihashi T; Nakao Y; Iwase M; Sadoshima S; Fujishima M
    Jpn Circ J; 1990 Feb; 54(2):192-200. PubMed ID: 1972412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal-induced antihypertensive effect of vasopressin in Doca-salt hypertension.
    Chiu EK; McNeill JR
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):458-61. PubMed ID: 2757802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.